Distinct Role of Gp130 Activation in Promoting Self-renewal Divisions by Mitogenically Stimulated Murine Hematopoietic Stem Cells

Overview

Journal Proc Natl Acad Sci U S A

Specialty Science

Date 2001 Feb 15

PMID 11172024

Citations 36

Authors

J Audet

C L Miller

S Rose-John

J M Piret

C J Eaves

Affiliations

Soon will be listed here.

Abstract

Previous studies have demonstrated hematopoietic stem cell amplification in vitro after the activation of three cell-surface receptors: flt3/flk2, c-kit, and gp130. We now show flt3-ligand and Steel factor alone will stimulate >85% of c-kit(+)Sca-1(+)lin(-) adult mouse bone marrow cells to proliferate in single-cell serum-free cultures, but concomitant retention of their stem cell activity requires additional exposure to a ligand that will activate gp130. Moreover, this response is restricted to a narrow range of gp130-activating ligand concentrations, above and below which hematopoietic stem cell activity is lost. These findings indicate a unique contribution of gp130 signaling to the maintenance of hematopoietic stem cell function when these cells are stimulated to divide with additional differential effects dictated by the intensity of gp130 activation.

Citing Articles

IL-11-An aging-related cytokine with opportunities for regulating hematopoiesis.

Kent D Hemasphere. 2024; 8(11):e70050.

PMID: 39564540 PMC: 11574441. DOI: 10.1002/hem3.70050.

Restoring T and B cell generation in X-linked severe combined immunodeficiency mice through hematopoietic stem cells adenine base editing.

Zhang L, Li K, Liu Z, An L, Wei H, Pang S Mol Ther. 2024; 32(6):1658-1671.

PMID: 38532630 PMC: 11184316. DOI: 10.1016/j.ymthe.2024.03.028.

Dissecting Interleukin-6 Classic and Trans-signaling in Inflammation and Cancer.

Garbers C, Rose-John S Methods Mol Biol. 2023; 2691:207-224.

PMID: 37355548 DOI: 10.1007/978-1-0716-3331-1_16.

Targeting IL-6 trans-signalling: past, present and future prospects.

Rose-John S, Jenkins B, Garbers C, Moll J, Scheller J Nat Rev Immunol. 2023; 23(10):666-681.

PMID: 37069261 PMC: 10108826. DOI: 10.1038/s41577-023-00856-y.

Lessons from early life: understanding development to expand stem cells and treat cancers.

Bain F, Che J, Jassinskaja M, Kent D Development. 2022; 149(20).

PMID: 36217963 PMC: 9724165. DOI: 10.1242/dev.201070.

References

Zanjani E, Almeida-Porada G, Livingston A, Flake A, Ogawa M . Human bone marrow CD34- cells engraft in vivo and undergo multilineage expression that includes giving rise to CD34+ cells. Exp Hematol. 1998; 26(4):353-60. View

Sato T, Laver J, Ogawa M . Reversible expression of CD34 by murine hematopoietic stem cells. Blood. 1999; 94(8):2548-54. View

Hirano T, Nakajima K, Hibi M . Signaling mechanisms through gp130: a model of the cytokine system. Cytokine Growth Factor Rev. 1998; 8(4):241-52. DOI: 10.1016/s1359-6101(98)80005-1. View

Bachmann M, Barner M, Kopf M . CD2 sets quantitative thresholds in T cell activation. J Exp Med. 1999; 190(10):1383-92. PMC: 2195700. DOI: 10.1084/jem.190.10.1383. View

Ramsfjell V, Bryder D, Bjorgvinsdottir H, Kornfalt S, Nilsson L, Borge O . Distinct requirements for optimal growth and In vitro expansion of human CD34(+)CD38(-) bone marrow long-term culture-initiating cells (LTC-IC), extended LTC-IC, and murine in vivo long-term reconstituting stem cells. Blood. 1999; 94(12):4093-102. View

Oostendorp R, Audet J, Eaves C . High-resolution tracking of cell division suggests similar cell cycle kinetics of hematopoietic stem cells stimulated in vitro and in vivo. Blood. 2000; 95(3):855-62. View

Ohtani T, Ishihara K, Atsumi T, Nishida K, Kaneko Y, Miyata T . Dissection of signaling cascades through gp130 in vivo: reciprocal roles for STAT3- and SHP2-mediated signals in immune responses. Immunity. 2000; 12(1):95-105. DOI: 10.1016/s1074-7613(00)80162-4. View

Ueda T, Tsuji K, Yoshino H, Ebihara Y, Yagasaki H, Hisakawa H . Expansion of human NOD/SCID-repopulating cells by stem cell factor, Flk2/Flt3 ligand, thrombopoietin, IL-6, and soluble IL-6 receptor. J Clin Invest. 2000; 105(7):1013-21. PMC: 377479. DOI: 10.1172/JCI8583. View

Gallacher L, Murdoch B, Wu D, Karanu F, Keeney M, Bhatia M . Isolation and characterization of human CD34(-)Lin(-) and CD34(+)Lin(-) hematopoietic stem cells using cell surface markers AC133 and CD7. Blood. 2000; 95(9):2813-20. View

10.

Zandstra P, Lauffenburger D, Eaves C . A ligand-receptor signaling threshold model of stem cell differentiation control: a biologically conserved mechanism applicable to hematopoiesis. Blood. 2000; 96(4):1215-22. View

11.

Maguer-Satta V, Oostendorp R, Reid D, Eaves C . Evidence that ceramide mediates the ability of tumor necrosis factor to modulate primitive human hematopoietic cell fates. Blood. 2000; 96(13):4118-23. View

12.

Unkeless J . Characterization of a monoclonal antibody directed against mouse macrophage and lymphocyte Fc receptors. J Exp Med. 1979; 150(3):580-96. PMC: 2185638. DOI: 10.1084/jem.150.3.580. View

13.

Metcalf D . Clonal analysis of proliferation and differentiation of paired daughter cells: action of granulocyte-macrophage colony-stimulating factor on granulocyte-macrophage precursors. Proc Natl Acad Sci U S A. 1980; 77(9):5327-30. PMC: 350051. DOI: 10.1073/pnas.77.9.5327. View

14.

Fazekas de St Groth . The evaluation of limiting dilution assays. J Immunol Methods. 1982; 49(2):R11-23. DOI: 10.1016/0022-1759(82)90269-1. View

15.

Taga T, Hibi M, Hirata Y, Yamasaki K, Yasukawa K, Matsuda T . Interleukin-6 triggers the association of its receptor with a possible signal transducer, gp130. Cell. 1989; 58(3):573-81. DOI: 10.1016/0092-8674(89)90438-8. View

16.

Szilvassy S, Humphries R, Lansdorp P, Eaves A, Eaves C . Quantitative assay for totipotent reconstituting hematopoietic stem cells by a competitive repopulation strategy. Proc Natl Acad Sci U S A. 1990; 87(22):8736-40. PMC: 55034. DOI: 10.1073/pnas.87.22.8736. View

17.

Yasukawa K, Saito T, Fukunaga T, Sekimori Y, Koishihara Y, Fukui H . Purification and characterization of soluble human IL-6 receptor expressed in CHO cells. J Biochem. 1990; 108(4):673-6. DOI: 10.1093/oxfordjournals.jbchem.a123261. View

18.

Novick D, Shulman L, Chen L, Revel M . Enhancement of interleukin 6 cytostatic effect on human breast carcinoma cells by soluble IL-6 receptor from urine and reversion by monoclonal antibody. Cytokine. 1992; 4(1):6-11. DOI: 10.1016/1043-4666(92)90029-q. View

19.

Green J, New H, Smith J . Responses of embryonic Xenopus cells to activin and FGF are separated by multiple dose thresholds and correspond to distinct axes of the mesoderm. Cell. 1992; 71(5):731-9. DOI: 10.1016/0092-8674(92)90550-v. View

20.

Van Dam M, Mullberg J, Schooltink H, Stoyan T, Brakenhoff J, Graeve L . Structure-function analysis of interleukin-6 utilizing human/murine chimeric molecules. Involvement of two separate domains in receptor binding. J Biol Chem. 1993; 268(20):15285-90. View